"We will continue to focus on a range of issues in relation to the PBS, of course, and important internal matters like governance, the Code of Conduct and listening to the membership - but our industry is also on the cusp of something quite extraordinary," says Vifor Pharma's James McDonnell. …
James McDonnell: Industry 'on the cusp of something quite extraordinary'
September 20, 2019 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
When the Government funds a health technology, the community makes certain assumptions
December 19, 2024 - - Latest News -
If this decision to undermine the TGA reflects a policy decision, be transparent about it
December 18, 2024 - - Latest News -
Race Oncology appoints Opthea founder to its board
December 18, 2024 - - Australian Biotech -
New listings and higher prescription volumes driving PBS spend
December 18, 2024 - - Latest News -
If you have ovarian cancer, genomic testing may open up new treatment option
December 18, 2024 - - BioPharma -
Cartherics secures G-Rex grant to support its ‘in house’ manufacturing program
December 18, 2024 - - Australian Biotech -
Researchers say Australia’s first mRNA vaccine candidate could address COVID ‘immune imprinting’
December 18, 2024 - - Australian Biotech